These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33581707)

  • 1. Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus.
    Er E; Ata A; Evin F; Altınok YA; Demir G; Özen S; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1533-1537. PubMed ID: 33581707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
    Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HbA
    Baldimtsi E; Amezcua S; Ulander M; Hyllienmark L; Olausson H; Ludvigsson J; Wahlberg J
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3825. PubMed ID: 38878301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HbA1c variability and long-term glycemic control are linked to diabetic retinopathy and glomerular filtration rate in patients with type 1 diabetes and multiethnic background.
    Rosa LCGFD; Zajdenverg L; Souto DL; Dantas JR; Pinto MVR; Salles GFDCM; Rodacki M
    J Diabetes Complications; 2019 Sep; 33(9):610-615. PubMed ID: 31227288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes.
    ; Ahmad I; ; Ali M; Hussain M;
    J Pak Med Assoc; 2024 Aug; 74(8):1441-1448. PubMed ID: 39160710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated albumin indicates peripheral diabetic neuropathy.
    Wang N; Guo C; Han P; Li T
    Acta Diabetol; 2016 Dec; 53(6):973-979. PubMed ID: 27573202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.
    Kilpatrick ES; Rigby AS; Atkin SL
    Diabetes Care; 2008 Nov; 31(11):2198-202. PubMed ID: 18650371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients.
    Jun JE; Lee SE; Lee YB; Ahn JY; Kim G; Jin SM; Hur KY; Lee MK; Kim JH
    Cardiovasc Diabetol; 2017 Oct; 16(1):127. PubMed ID: 29017498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.
    Lu J; Ma X; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Zhou J
    J Diabetes Investig; 2019 May; 10(3):753-759. PubMed ID: 30306722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study.
    Msanga D; Reis K; Kayange N; Bakalemwa R; Kidenya B; Hau D; Mwanansao C; Mahamba D; Ottaru S; Kwiyolecha E; Peck R
    Ann Glob Health; 2020 Apr; 86(1):43. PubMed ID: 32346524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA1c levels in children with type 1 diabetes and correlation to diabetic retinopathy.
    Andreasson R; Ekelund C; Landin-Olsson M; Nilsson C
    J Pediatr Endocrinol Metab; 2018 Mar; 31(4):369-374. PubMed ID: 29494341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early risk stratification in pediatric type 1 diabetes.
    Broe R
    Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.
    Su JB; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ
    Cardiovasc Diabetol; 2018 Mar; 17(1):47. PubMed ID: 29598819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
    Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
    Diabetes Care; 2017 Jun; 40(6):777-783. PubMed ID: 28404658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA
    Wang JM; Miao MY; Jia YP; Wang XW; Wu XB; Wan ZX; Zheng Y; Qin LQ; Li FR; Chen GC
    Diabetes Res Clin Pract; 2024 Feb; 208():111100. PubMed ID: 38246509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.